Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression

Human Psychopharmacology

Volumn 28, Issue 1, 2013, Pages 7-14

  Egami, Maki ^a   Imamura, Yoshiomi ^a   Nabeta, Hiromi ^a   Mizoguchi, Yoshito ^a   Yamada, Shigeto ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

depression; MHPG; mirtazapine; paroxetine; saliva

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; BENZODIAZEPINE DERIVATIVE; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; SULPIRIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MASS FRAGMENTOGRAPHY; NAUSEA; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SALIVA LEVEL; SEX DIFFERENCE; SOMNOLENCE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIANSERIN; MIDDLE AGED; SALIVA; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84873844325     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2273     Document Type: Article

References (35)

1. Asberg M, Bertilsson L, Mårtensson B, Scalia-Tomba GP, Thorén P, Träskman-Bendz L,. 1984. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 69: 201-219.
2. Azorin JM, Raucoules D, Valli M, et al,. 1990. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls. Neuropsychobiology 23: 18-24.
3. Bowden CL, Koslow S, Maas JW, Davis J, Garver DL, Hanin I,. 1987. Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine. J Psychiatr Res 21: 111-128.
4. Carney RM, Blumenthal JA, Freedland KE, et al,. 2005. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 165: 1486-1491.
5. DeBellis MD, Geracioti TD, Altemus M, Kling MA,. 1993. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. Biol Psychiatry 33: 636-641.
6. Gaertner HJ, Golfinopoulos G, Breyer-Pfaff U,. 1982. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level. Pharmacopsychiatria 15: 170-174.
7. Garvey MJ, Tuason VB,. 1996. Urinary levels of 3-methoxy-4- hydroxyphenylglycol predict symptom severity in selected patients with unipolar depression. Psychiatry Res 62: 171-177.
8. Geracioti TD, Jr, Loosen PT, Ekhator NN, et al,. 1997. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling. Depress Anxiety 6: 89-94.
9. Giedke H, Gaertner HJ, Mahal A,. 1982. Diurnal variation of urinary MHPG in unipolar and bipolar depressives. Acta Psychiatr Scand 66: 243-53.
10. Hamer M, Tanaka G, Okamura H, Tsuda A, Steptoe A,. 2007. The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol Psychol 74: 20-25.
11. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M,. 1999. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 89: 97-106.
12. Jimerson DC, Insel TR, Reus VI, Kopin IJ,. 1983. Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry 40: 173-176.
13. Ko HC, Lu RB, Shiah IS, Hwang CC,. 1997. Plasma free 3-methoxy-4- hydroxyphenylglycol predicts response to fluoxetine. Biol Psychiatry 41: 774-781.
14. Koenigsberg MH, Teicher MH, Mitropoulou V, et al,. 2004. Twenty-four hours monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatry Res 38: 503-511.
15. Koslow SH, Maas JW, Bowden CL, Davis JM, Hanin I, Javaid J,. 1983. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Arch Gen Psychiatry 40: 999-1010.
16. Li GY, Ueki H, Yamamoto Y, Yamada S,. 2006. Association between the scores on the General Health Questionnaire-28 and the saliva levels of 3-methoxy-4-hydroxyphenylglycol in normal volunteers. Biological Psychol 73: 209-211.
17. Lundmark J, Wålinder J, Alling C, Manniche PM, Dalgaard L,. 1994. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients. Eur Neuropsychopharmacol 4: 1-6.
18. Maas JW, Fawcett JA, Dekirmenjian H,. 1972. Catecholamine metabolism, depressive illness and drug response. Arch Gen Psychiatry 26: 252-262.
19. Mooney JJ, Schatzberg AF, Cole JO, et al,. 1991. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants. J Clin Psychopharmacol 11: 339-343.
20. Mooney JJ, Schatzberg AF, Cole JO, et al,. 1998. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylatecyclase. Biol Psychiatry 23: 543-559.
21. Nemeroff CB, Owens MJ,. 2004. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis. CNS Spectr 6 (Suppl 4): 23-31.
22. Potter WZ, Karoum F, Linnoila M,. 1984. Common mechanism of action of biochemically "specific" antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 8: 153-161.
23. Rocha FL, Fuzikawa C, Riera R, Hara C,. 2012. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis. J Clin Psychopharmacol 32: 278-281.
24. Rosenbaum AH, Maruta T, Schatzberg AF,. 1983. Towards a biochemical classification of depressive disorders. VII: urinary free cortisol and urinary MHPG in depressions. Am J Psychiatry 140: 314-318.
25. Rubin AL, Price LH, Charney DS, Heninger GR,. 1985. Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Res 15: 5-15.
26. Samson JA, Mirin SM, Hauser ST, Fenton BT, Schildkraut JJ,. 1992. Learned helplessness and urinary MHPG levels in unipolar depression. Am J Psychiatry 149: 806-809.
27. Schatzberg AF, Orsulak PJ, Rosenbaum AH, et al,. 1982. Toward a biochemical classification of depressive disorders, V: heterogeneity of unipolar depressions. Am J Psychiatry 139: 471-475.
28. Seckl JR, Fink G,. 1992. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 55: 621-626.
29. Sheline Y, Bardgett ME, Csernansky JG,. 1997. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 17: 11-14.
30. Shinkai K, Yoshimura R, Ueda N, Okamoto K, Nakamura J,. 2004. Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment. J Clin Psychopharmacol 24: 11-17.
31. Ueda N, Yoshimura R, Shinkai K, Nakamura J,. 2002. Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression. Pharmacopsychiatry 35: 175-181.
32. Vestergaard P, Sørensen T, Hoppe E, Rafaelsen OJ, Yates CM, Nicolaou N,. 1978. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand 58: 88-96.
33. Watanabe I, Li GY, Imamura Y, et al,. 2012. Association of saliva 3-methoxy-4-hydroxyphenylglycol levels and a later depressive state in older subjects living in a rural community: 3-year follow-up study. Int J Geriatric Psychiatry 27: 321-326.
34. Yamada S, Yajima J, Harano M, et al,. 1998. Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety. Int Clin Psychopharmacol 13: 213-217.
35. Yamada S, Yamauchi K, Yajima J, et al,. 2000. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders. Psychiatry Res 93: 217-223.